Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation.

ABSTRACT:

Background

Up to 70% of suspected Lynch syndrome patients harboring MMR deficient tumors lack identifiable germline pathogenic variants in MMR genes, being referred to as Lynch-like syndrome (LLS). Previous studies have reported biallelic somatic MMR inactivation in a variable range of LLS-associated tumors. Moreover, translating tumor testing results into patient management remains controversial. Our aim is to assess the challenges associated with the implementation of tumoral MMR gene testing in routine workflows.

Methods

Here, we present the clinical characterization of 229 LLS patients. MMR gene testing was performed in 39 available tumors, and results were analyzed using two variant allele frequency (VAF) thresholds (≥5% and ≥10%).

Results and discussion

More bia

SUBMITTER: Rofes P 

PROVIDER: S-EPMC10983805 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature